HPV-16E6 can induce multiple site phosphorylation of p53
- PMID: 19148510
HPV-16E6 can induce multiple site phosphorylation of p53
Abstract
Modulation of the activity of tumor suppressor p53 is a key event in the replication of many viruses. They could manipulate p53 function through modification of phosphorylation for their own purpose. However, there are scarce data on the relationship between high risk human papillomavirus (HPV) E6 protein and p53 phosphorylation status. Therefore, we used a mammalian green fluorescence protein (GFP) expression system to express HPV-16E6 with GFP fusion proteins in wild-type p53 cell lines, 293T, MCF-7, and SMMC-7721 to trace the traffic and subcellular location of E6 protein. By immunoblotting, we determined the positive phosphorylated sites of p53 in the context of HPV-16E6. Using immunofluorescence techniques, we observed the distribution of phosphorylated p53 in all the cells we used. In conclusion, HPV-16E6 was predominantly located in nuclei of wild-type p53 cells, and it was able to induce phosphorylation of p53 at multiple sites, such as Ser15, Ser20, and Ser392. The level and time of these phosphorylated sites of p53 were different in HPV-16E6 expressing cells. Furthermore, the phosphorylated p53 was localized in the nuclei together with HPV-16E6.
Similar articles
-
GFP/HPV-16E6 fusion protein induces apoptosis in MCF-7 and 293T cells using a transient expression system.Oncol Rep. 2012 Nov;28(5):1673-80. doi: 10.3892/or.2012.1976. Epub 2012 Aug 22. Oncol Rep. 2012. PMID: 22922869
-
In GFP with high risk HPV-18E6 fusion protein expressed 293T and MCF-7 cells, the endogenous wild-type p53 could be transiently phosphorylated at multiple sites.J Exp Clin Cancer Res. 2008 Sep 8;27(1):35. doi: 10.1186/1756-9966-27-35. J Exp Clin Cancer Res. 2008. PMID: 18778462 Free PMC article.
-
Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification.Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1262-7. doi: 10.1158/1055-9965.EPI-05-0778. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16835321
-
Human papillomavirus in HNSCC: recognition of a distinct disease type.Hematol Oncol Clin North Am. 2008 Dec;22(6):1125-42, vii. doi: 10.1016/j.hoc.2008.08.006. Hematol Oncol Clin North Am. 2008. PMID: 19010263 Review.
-
Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.Rev Med Virol. 2009 Mar;19(2):97-113. doi: 10.1002/rmv.605. Rev Med Virol. 2009. PMID: 19156753 Review.
Cited by
-
Analysis of ROC: The value of HPV16 E6 protein in the diagnosis of early stage cervical carcinoma and precancerous lesions.Oncol Lett. 2016 Sep;12(3):1769-1772. doi: 10.3892/ol.2016.4844. Epub 2016 Jul 11. Oncol Lett. 2016. PMID: 27588123 Free PMC article.
-
Human papillomavirus 18 E6 inhibits phosphorylation of p53 expressed in HeLa cells.Cell Biosci. 2012 Jan 13;2:2. doi: 10.1186/2045-3701-2-2. Cell Biosci. 2012. PMID: 22244155 Free PMC article.
-
Interferon-β induces cellular senescence in cutaneous human papilloma virus-transformed human keratinocytes by affecting p53 transactivating activity.PLoS One. 2012;7(5):e36909. doi: 10.1371/journal.pone.0036909. Epub 2012 May 16. PLoS One. 2012. Retraction in: PLoS One. 2019 Mar 15;14(3):e0214341. doi: 10.1371/journal.pone.0214341. PMID: 22615843 Free PMC article. Retracted.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous